Journey Medical's new rosacea treatment will rival industry giant Galderma's Oracea in the treatment of rosacea.
Fortress Biotech, Inc. (NASDAQ: FBIO) announced through its majority-controlled subsidiary, Journey Medical Corporation, that the U.S. Food and Drug Administration (FDA) has approved Emrosiâ„¢ ...
As demand for popular weight-loss drugs like Wegovy and Zepbound skyrockets, patients are taking dosage amounts into their ...
Key trial focus: PK/PD in healthy subjects, with PK bracketed by standard epinephrine injections No placebo-controlled efficacy studies required NORTH HAVEN, Conn., Nov. 05, 2024 (GLOBE NEWSWIRE) -- ...
Suhas Subramanyam began his political journey driven by a commitment to public service ... He’s been a leading advocate for ...
Journey Medical has claimed FDA approval for its Emrosi therapy for rosacea, which it thinks could become a "standard of care ...
In the ever-evolving world of wellness and self-care, finding the right supplement can sometimes feel like searching for a ...
The FDA approved Emrosi (minocycline hydrochloride extended-release capsules) for the treatment of inflammatory lesions of rosacea in adults.
Approval based on Phase 3 data showing significantly more children aged 1 to 11 years on Dupixent achieved histological disease remission at 16 ...
3h
Analyst Jason Butler from JMP Securities reiterated a Buy rating on Aquestive Therapeutics (AQST – Research Report) and keeping the price ...
These drugs are collectively known as GLP-1 agonists because they mimic the body’s natural hormone GLP-1, which regulates ...
Organon, which is seeking approval of Vtama as a treatment for atopic dermatitis, said the FDA set a new target action date of March 12 for a decision after requesting the final datasets and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback